Solid Biosciences, Inc. (SLDB)
7.02
+0.14
(+2.03%)
USD |
NASDAQ |
May 27, 16:00
7.04
+0.02
(+0.28%)
After-Hours: 20:00
Solid Biosciences Shareholders Equity (Quarterly) : 374.13M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Anika Therapeutics, Inc. | 133.90M |
| BioCryst Pharmaceuticals, Inc. | -553.84M |
| Plus Therapeutics, Inc. | 11.96M |
| Perspective Therapeutics, Inc. | 347.44M |
| AVITA Medical, Inc. | -23.17M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 422.89M |
| Total Liabilities (Quarterly) | 48.76M |
| Debt to Equity Ratio | 0.0552 |
| Current Ratio | 13.10 |
| Net Debt Paydown Yield | 0.10% |